Brian R. Murphy

Active 1972–2021

182
Papers
28,561
Citations
101
h-index
178
i10-index

Citations

Citations per year for Brian R. Murphy1973: 3 citations1974: 3 citations1975: 6 citations1976: 6 citations1977: 3 citations1978: 4 citations1979: 5 citations1980: 6 citations1981: 7 citations1982: 14 citations1983: 18 citations1984: 14 citations1985: 21 citations1986: 50 citations1987: 36 citations1988: 41 citations1989: 43 citations1990: 43 citations1991: 62 citations1992: 63 citations1993: 70 citations1994: 115 citations1995: 109 citations1996: 78 citations1997: 146 citations1998: 153 citations1999: 215 citations2000: 230 citations2001: 233 citations2002: 228 citations2003: 222 citations2004: 351 citations2005: 442 citations2006: 392 citations2007: 339 citations2008: 395 citations2009: 324 citations2010: 288 citations2011: 324 citations2012: 209 citations2013: 283 citations2014: 219 citations2015: 192 citations2016: 166 citations2017: 116 citations2018: 96 citations2019: 487 citations2020: 973 citations2021: 544 citations2022: 319 citations2023: 205 citations2024: 350 citations2025: 169 citations2026: 6 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,198 citing papers, 37.6% of this breakdownUnited Kingdom: 536 citing papers, 6.3% of this breakdownChina: 518 citing papers, 6.1% of this breakdownGermany: 315 citing papers, 3.7% of this breakdownFrance: 293 citing papers, 3.4% of this breakdownCanada: 273 citing papers, 3.2% of this breakdownNetherlands: 241 citing papers, 2.8% of this breakdownJapan: 234 citing papers, 2.7% of this breakdownAustralia: 221 citing papers, 2.6% of this breakdownIndia: 175 citing papers, 2.1% of this breakdownSwitzerland: 169 citing papers, 2% of this breakdownItaly: 164 citing papers, 1.9% of this breakdown
0%37.6%Other 25.6%

Fields

  • Medicine76.2%
  • Computer Science10.6%
  • Immunology and Microbiology4.7%
  • Biochemistry, Genetics and Molecular Biology4.3%
  • Agricultural and Biological Sciences1.8%
  • Environmental Science0.4%
  • Other2%

Topics

  • Respiratory viral infections research10.1%
  • Influenza Virus Research Studies6.7%
  • SARS-CoV-2 and COVID-19 Research6%
  • Viral gastroenteritis research and epidemiology4.5%
  • Viral Infections and Vectors4.3%
  • Mosquito-borne diseases and control3.4%
  • Other65%

Coauthors

All papers

Open in search
  1. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range

    Authors: , , - Journal of Virology 1993 cited by 948

  2. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

    Authors: , , , , , , , , - Nature Medicine 2004 cited by 708

  3. Prospects for a dengue virus vaccine

    Authors: , , , - Nature Reviews Microbiology 2007 cited by 624

  4. Recombinant Human Metapneumovirus Lacking the Small Hydrophobic SH and/or Attachment G Glycoprotein: Deletion of G Yields a Promising Vaccine Candidate

    Authors: , , , , , , , - Journal of Virology 2004 cited by 237

  5. Infection of Nonhuman Primates with Recombinant Human Metapneumovirus Lacking the SH, G, or M2-2 Protein Categorizes Each as a Nonessential Accessory Protein and Identifies Vaccine Candidates

    Authors: , , , , , - Journal of Virology 2005 cited by 176

  6. Genetic diversity between human metapneumovirus subgroups

    Authors: , , , , , , - Virology 2003 cited by 267

  7. The Secreted Form of Respiratory Syncytial Virus G Glycoprotein Helps the Virus Evade Antibody-Mediated Restriction of Replication by Acting as an Antigen Decoy and through Effects on Fc Receptor-Bearing Leukocytes

    Authors: , , , , , , - Journal of Virology 2008 cited by 182

  8. A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial

    Authors: , , , , , , , , , , , , , , , , - The Journal of Infectious Diseases 2013 cited by 166

  9. A Real-World Evidence Study of CDK4/6 Inhibitor Treatment Patterns and Outcomes in Metastatic Breast Cancer by Germline BRCA Mutation Status

    Authors: , , , , , , , , , , - Oncology and Therapy 2021 cited by 61

  10. Association of Serum Anti-Neuraminidase Antibody with Resistance to Influenza in Man

    Authors: , , - New England Journal of Medicine 1972 cited by 377

  11. Identification of a Recombinant Live Attenuated Respiratory Syncytial Virus Vaccine Candidate That Is Highly Attenuated in Infants

    Authors: , , , , , , , , , , , , - The Journal of Infectious Diseases 2005 cited by 285

  12. Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity

    Authors: , - Journal of Clinical Microbiology 1988 cited by 225

  13. Incidence and Cost of Major Adverse Cardiovascular Events and Major Adverse Limb Events in Patients With Chronic Coronary Artery Disease or Peripheral Artery Disease

    Authors: , , , , , , , , - The American Journal of Cardiology 2019 cited by 55

  14. Immune Response to Dengue Virus and Prospects for a Vaccine

    Authors: , - Annual Review of Immunology 2011 cited by 447

  15. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro : Clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1997 cited by 416

  16. Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity

    Authors: , , , , , , - Virology 2005 cited by 151

  17. Deletion of M2 Gene Open Reading Frames 1 and 2 of Human Metapneumovirus: Effects on RNA Synthesis, Attenuation, and Immunogenicity

    Authors: , , , , , , , , - Journal of Virology 2005 cited by 112

  18. From Concept to Commerce: Developing a Successful Fungal Endophyte Inoculant for Agricultural Crops

    Authors: , , - Journal of Fungi 2018 cited by 94

  19. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity

    Authors: , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2004 cited by 414

  20. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine

    Authors: , , , , , , , - Journal of Clinical Microbiology 1986 cited by 308

  21. Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes

    Authors: , , , , , - Virology 2004 cited by 146

  22. Development of a Live Attenuated Dengue Virus Vaccine Using Reverse Genetics

    Authors: , , , - Viral Immunology 2006 cited by 108

  23. Mechanisms of Host Defense following Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) Pulmonary Infection of Mice

    Authors: , , , - The Journal of Immunology 2004 cited by 355

  24. Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

    Authors: , , , , , , , , , , , , - American Journal of Tropical Medicine and Hygiene 2001 cited by 293